Archisha Mukherjee

In 2024, China’s National Medical Products Administration approved 83 new drugs, a 12% year-on-year increase, significantly outpacing the US Food and Drug Administration’s 50 novel medicines.

How China rewrote the rules of drug innovation

In an era where AI-driven drug discovery accelerates candidate generation faster than traditional systems can evaluate them, regulatory velocity becomes a binding...